ACAD
Acadia Pharmaceuticals Inc
$21.32
+1.77% (+$0.37)
Volume
1.66M
52W High
$28.35
52W Low
$19.69
Market Cap
$3.94B
Next Earnings Report
Last Reported
May 13, 2026 Missed
Actual: $0.02
vs. Consensus: $0.05
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q1 2026
May 13, 2026
1-Day:
-0.41%
5-Day:
-6.72%
Q1 2026
May 6, 2026
1-Day:
+5.03%
5-Day:
+1.49%
Q4 2025
Mar 2, 2026
1-Day:
-1.36%
Q4 2025
Feb 25, 2026
1-Day:
-1.32%
5-Day:
-8.65%
Revenue & Financial Performance
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $284.0M | +9.4% | 90.8% | 6.1% | $273.6M |
| Q3'25 | $278.6M | +11.3% | 92.2% | 12.8% | $71.8M |
| Q2'25 | $264.6M | +9.3% | 92.2% | 12.2% | $26.7M |
| Q1'25 | $244.3M | +18.7% | 91.7% | 7.9% | $19.0M |
| Q4'24 | $259.6M | +12.4% | 91.6% | 59.1% | $143.7M |
| Q3'24 | $250.4M | +18.3% | 92.5% | 12.6% | $32.8M |
| Q2'24 | $242.0M | +46.4% | 92.5% | 12.6% | $33.4M |
| Q1'24 | $205.8M | +73.8% | 88.9% | 7.4% | $16.6M |
Company Information
Symbol
ACAD
Company
Acadia Pharmaceuticals Inc
Market Cap
$3.94B